Company & Group Structure
Industrial biotechnology platform with scalable processes
BRAIN Biotech AG is a biotechnology company focused on specialty enzymes, bioprocess development and biobased manufacturing solutions for industrial applications.
The Group combines proprietary technology platforms, application expertise and industrial-scale production capabilities to support customers in the food, life science and environmental sectors.
Using microorganisms, enzymes and fermentation technologies, BRAIN Biotech develops products and processes designed to improve efficiency, product performance and sustainability across industrial value chains.
Diversified Business Model
The Group operates through two business units:
BRAINBiocatalysts
BRAINBiocatalysts is the Group’s commercial core business and focuses on the development, production and marketing of specialty enzymes, proteins and functional ingredients.
The business combines:
- proprietary enzyme technologies
- strain engineering capabilities
- scalable fermentation and downstream processing
- application-specific product development
In addition to its product portfolio, BRAINBiocatalysts provides integrated CDMO services covering the full development cycle from enzyme discovery to industrial manufacturing.
BRAINBioIncubator
BRAINBioIncubator focuses on research-driven innovation projects and early-stage technology development.
The business unit advances proprietary technology assets and selected pharmaceutical and industrial biotechnology programs with long-term value creation potential.
Integrated Value Chain, Capabilities and Capacities
BRAIN combines research, development and manufacturing within one integrated operating platform.
Core competencies include:
- enzyme discovery and engineering
- microbial strain development
- bioprocess optimization
- fermentation scale-up
- industrial manufacturing
Fermentation capacity in the BRAIN Biotech Group:
- Pilot scale fermenters (≤ 750 L)
- Manufacturing scale (2 x 10 m3)
- Subcontractor network (15 - 50 m3)
BRAIN Biotech´s integrated approach reduces development complexity, accelerates transfer into commercial production and supports long-term customer relationships.
International Production Footprint
The Group operates production and development sites in:
- the United Kingdom
- continental Europe
- the United States
This international footprint provides manufacturing flexibility, proximity to key markets and scalable production capabilities.
Focus on Sustainable Industrial Solutions
BRAIN Biotech addresses growing demand for more sustainable industrial processes and bio-based alternatives.
Its technologies support customers in:
- improving resource efficiency
- reducing process complexity
- lowering environmental impact
- replacing conventional chemical processes with biological solutions
The Group therefore operates at the intersection of biotechnology innovation, industrial scalability and sustainability-driven market demand.
Financial and Organizational Profile
BRAIN Biotech AG is the parent company of the BRAIN Biotech Group. The group´s headquarter is located in Zwingenberg, South Hesse, Germany.
BRAIN Biotech AG has been listed in the Prime Standard segment of the Frankfurt Stock Exchange since February 9, 2016 (ticker symbol: BNN; securities identification number: ISIN DE0005203947/WKN 520394).
In fiscal year 2024/25, the Group employed approximately 280 people and generated revenues of EUR 49.6 million.
